Aura Biosciences closes $4.5M Series A, forms NIH deal – Mass High Tech


Mass High Tech
Aura Biosciences closes $4.5M Series A, forms NIH deal
Mass High Tech
Schiller has focused on basic biology and vaccine development related to human papillomavirus (HPV), which can cause cancer. Schiller and colleague Douglas R. Lowy, MD, both of the Laboratory of Cellular Oncology, Center for Cancer Research at NCI,
Aura Bioscences Raises $4.5M to Advance Nano-Drug Weapon Against CancerXconomy

all 2 news articles »

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>